
Executive Team
Under the leadership of Chief Executive Officer, Mr. Enrique Conterno FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 600 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.

Enrique Conterno
Chief Executive Officer

Kirk Christoffersen
Chief Business Officer

Christine L. Chung
Senior Vice President,
China Operations
Mark Eisner, M.D.,
M.P.H.
Chief Medical Officer

Juan Graham
Chief Financial Officer
John Hunter, Ph.D.
Chief Scientific Officer
Michael D. Lowenstein,
J.D.
Chief Legal Officer
Leanne C. Price, J.D.
Chief Intellectual
Property Officer
Tricia Stewart
Chief People Officer

Thane Wettig
Chief Commercial Officer
